Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Androxal vs AndroGel in Men with Secondary Hypogonadism
NCT01993225Phase 3Completed
- Sponsor
- Repros Therapeutics Inc.
- Start
- Jan 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enclomiphene in secondary hypogonadism (HH), sponsored by Repros Therapeutics Inc.. Started Jan 2014; status: completed.
02
Drugs
enclomiphene
03
Conditions
secondary hypogonadism (HH)
Beyond the preview
Go deeper on NCT01993225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993225.